Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease
- 16 March 2007
- journal article
- research article
- Published by Elsevier in NeuroImage
- Vol. 36 (2), 298-312
- https://doi.org/10.1016/j.neuroimage.2007.03.004
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challengeNeuroImage, 2006
- Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 StudiesJournal of Cerebral Blood Flow & Metabolism, 2006
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and MemoryJournal of Neuroscience, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNTSynapse, 2002
- Positron Emission Tomography Compartmental ModelsJournal of Cerebral Blood Flow & Metabolism, 2001
- Improved Signal-to-Noise Ratio in Parametric Images by Cluster AnalysisNeuroImage, 1999
- A modeling-based factor extraction method for determining spatial heterogeneity of Ga-68 EDTA kinetics in brain tumorsIEEE Transactions on Nuclear Science, 1997
- Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984